Medications initially developed for managing diabetes and obesity are broadening their therapeutic applications. Recently, treatments based on the hormone GLP-1 have demonstrated benefits not only in weight loss and improved glycemic control but also in various...
The Indian healthcare market is bracing for a significant change as more than twenty generic variants of semaglutide, a highly sought-after drug for obesity and diabetes, are set to be introduced in the coming weeks. This...
India is developing its first National Obesity Guidelines after Prime Minister Narendra Modi’s Independence Day warning that obesity has become a “silent crisis” for...
American कंपनी Eli Lilly ने भारत में वजन घटाने की दवा Mounjaro लॉन्च की, जिसकी कीमत₹14,000 से ₹17,500 प्रति माह होगी। यह दवा Blood Sugar कंट्रोल और भूख कम करने में मदद करतीहै। Obesity और Diabetes से जूझ रहे लोगों के लिए यह एक क्रांतिकारी कदम है।
Eli Lilly Weight-Loss Drug अब भारत में...